-
Examining the three arms of the ACCORD trial; and FDA Actions: clopidogrel, dexlansoprazole, and tamsulosin.
-
Churg-Strauss syndrome is an immune-mediated disorder that commonly affects the peripheral nervous system.
-
Cholesterol ester transfer protein gene alleles may confer longevity as well as a reduced risk for Alzheimer's disease.
-
PPN DBS may be able to improve gait and postural stability in advanced Parkinson's disease. Although double-blind studies with small sample size did not confirm this effect, further studies are required for better understanding of the effects of PPN DBS in Parkinson's disease.
-
Camptocormia may occur in a wide variety of central and peripheral nervous system disorders, including primary muscle disease.
-
Intermittent fasting may reduce the risk and consequences of stroke in younger, rather than older animals
-
FDA is reviewing safety of TZDs; SSRI use with tamoxifen; Metformin smells like fish; FDA Actions.
-
-
A knock-in mouse model of a specific variant of familial hemiplegic migraine links the clinical manifestations of this rare migraine symptom with the triggering and propagation of cortical spreading depression and other unique characteristics of migraine.
-
Vaccines appear to be safe for patients who have been previously diagnosed with GBS or CIDP, and are recommended in appropriate individuals.
